MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer

Arnaud Augert, Haritha Mathsyaraja, Ali H. Ibrahim, Brian Freie, Michael J. Geuenich, Pei Feng Cheng, Sydney P. Alibeckoff, Nan Wu, Joseph B. Hiatt, Ryan Basom, Adi Gazdar, Lucas B. Sullivan, Robert N. Eisenman, David MacPherson

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Small cell lung cancer (SCLC) is a highly aggressive and lethal neoplasm. To identify candidate tumor suppressors we applied CRISPR/Cas9 gene inactivation screens to a cellular model of early-stage SCLC. Among the top hits was MAX, the obligate heterodimerization partner for MYC family proteins that is mutated in human SCLC. Max deletion increases growth and transformation in cells and dramatically accelerates SCLC progression in an Rb1/Trp53-deleted mouse model. In contrast, deletion of Max abrogates tumorigenesis in MYCL-overexpressing SCLC. Max deletion in SCLC resulted in derepression of metabolic genes involved in serine and one-carbon metabolism. By increasing serine biosynthesis, Max-deleted cells exhibit resistance to serine depletion. Thus, Max loss results in metabolic rewiring and context-specific tumor suppression.

Original languageEnglish (US)
Pages (from-to)97-114.e7
JournalCancer cell
Volume38
Issue number1
DOIs
StatePublished - Jul 13 2020
Externally publishedYes

Keywords

  • cancer
  • CRISPR-Cas9 genetic screens
  • MAX
  • mouse model
  • MYC
  • SCLC
  • serine and one-carbon metabolism
  • small cell lung cancer
  • Transcriptional regulation
  • tumor suppressor genes

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this